Dow Jones

40 802,04

1,47%

DAX

Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NYSE
Teva Pharmaceutical Industries Ltd (TEVA)
Teva Pharmaceutical Industries Ltd (TEVA) Actualités

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NYSE:TEVA

<< Précédent 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
12/06/2013	22h06	Business Wire	Teva to Present at the Goldman Sachs 34th Annual Global Healthcare Conference	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
12/06/2013	16h26	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
12/06/2013	14h58	Dow Jones News	Teva: Study Shows Combined Use of Laquinimod Improves Renal Function for Lupus	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
12/06/2013	14h50	Dow Jones News	Pfizer, Takeda To Get Total $2.15 Billion In Patent Settlement	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
12/06/2013	14h25	Business Wire	Teva Reaches Settlement Agreement with Pfizer and Nycomed Regarding Generic Protonix® (Pantoprazole) Tablets	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
12/06/2013	14h00	Business Wire	Teva and Active Biotech Report Positive Results from Phase IIa Study of Laquinimod in Active Lupus Nephritis	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
10/06/2013	14h00	PR Newswire (US)	New Studies, Regulatory Submissions, and Leadership Changes - Research Report on St. Jude Medical, Teva Pharmaceutical Indust...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
03/06/2013	07h00	Business Wire	Teva’s Lonquex®(XM22 lipegfilgrastim) Recommended for Approval in the EU for the Reduction of Chemotherapy-Induced Neutrop...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
30/05/2013	14h02	Business Wire	Teva Announces FDA Acceptance of sNDA for a Higher Concentration Dose of COPAXONE® Given Three Times a Week	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
14/05/2013	16h35	Business Wire	Teva to Present at the Bank of America Merrill Lynch 2013 Health Care Conference	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
08/05/2013	18h17	Dow Jones News	UPDATE: Teva, Alexza Pharmaceuticals In Inhaler Licensing Pact	NYSE:TEVA	Teva Pharmaceutical Industries Ltd.
08/05/2013	17h55	Business Wire	New Data Presented Demonstrates Ovulatory Effect of Teva Women’s Health’s Investigational 28-Day Oral Contraceptive	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
08/05/2013	15h34	Dow Jones News	Teva Pharmaceutical, Alexza Pharmaceuticals Reach Licensing Pact for Adasuve	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
08/05/2013	14h35	PR Newswire (US)	Alexza Announces Conference Call to Discuss Agreement with Teva to Market ADASUVE® in the U.S.	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
08/05/2013	14h30	Business Wire	Teva and Alexza Announce Teva’s License to Market ADASUVE® in the U.S.	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
08/05/2013	14h30	PR Newswire (US)	Teva and Alexza Announce Teva's License to Market ADASUVE® in the U.S.	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
06/05/2013	16h45	Business Wire	Teva Women’s Health to Present New Data at the 61st Annual Meeting of the American Congress of Obstetricians and Gynecologi...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
02/05/2013	22h01	PR Newswire (Canada)	OncoGenex Pharmaceuticals, Inc. Provides Clinical Development Program Overview and Reports Financial Results for First Quarte...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
02/05/2013	17h02	Dow Jones News	UPDATE: Teva Pharmaceutical's Profit Falls on Lower Generic Sales	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
02/05/2013	13h00	Business Wire	Teva Reports First Quarter 2013 Results	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
01/05/2013	12h30	PR Newswire (US)	OncoGenex Announces Plans for the Initiation of the Rainier™ Clinical Trial Evaluating OGX-427 in Combination with ABRAXANE...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
01/05/2013	00h49	Business Wire	FDA Approves Over-The-Counter Availability of Plan B One-Step® (levonorgestrel) tablet 1.5 mg for Consumers 15 and Over	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
01/05/2013	00h31	Dow Jones News	FDA Approves Teva's Plan B Pill for Women 15 Years of Age and Older Without Prescrption	NYSE:TEVA	Teva Pharmaceutical Industries Ltd.
30/04/2013	14h01	PR Newswire (Canada)	OncoGenex Announces that the Borealis-2™ Clinical Trial of OGX-427 in Previously Treated Metastatic Bladder Cancer is now O...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
29/04/2013	14h00	Business Wire	Teva Expands Management Team with Appointment of Paul J. Sekhri as Group Executive Vice President, Global Bus. Development & ...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
24/04/2013	13h00	Business Wire	Teva Establishes Global Specialty Medicines Group	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
23/04/2013	14h00	PR Newswire (US)	More Than Half of Nasal Allergy Sufferers Experience Sleep Issues, Yet Many Fail to Adequately Prepare in Advance of Peak All...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
23/04/2013	14h00	Business Wire	Teva and Xenon Announce FDA Orphan Drug Designation for Pain Drug XEN402	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
17/04/2013	14h45	Business Wire	Teva Presented New Data from Phase III Clinical Trial of Milprosa™ (Progesterone) Vaginal Ring at the 61st Annual Meeting o...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
16/04/2013	14h00	PR Newswire (US)	Apolo Anton Ohno And Teva Respiratory Announce Finalists In National EIB All Stars™ Contest	NYSE:TEVA	Teva Pharmaceutical Industries Ltd